Fabio Robusto
Overview
Explore the profile of Fabio Robusto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nacchiero E, Giotta M, Robusto F, Metta M, Ronghi V, Elia R, et al.
Melanoma Res
. 2024 Sep;
34(6):519-527.
PMID: 39321036
Currently, wide local excision is recommended after the primary excision of cutaneous melanomas. The definition of margins for wide local excision indicated by the guidelines has remained unchanged over the...
2.
Bertero E, Robusto F, Rulli E, DEttorre A, Bisceglia L, Staszewsky L, et al.
JACC CardioOncol
. 2022 May;
4(1):98-109.
PMID: 35492831
Background: Studies assessing whether heart failure (HF) is associated with cancer and cancer-related mortality have yielded conflicting results. Objectives: This study assessed cancer incidence and mortality according to pre-existing HF...
3.
Staszewsky L, Baviera M, Tettamanti M, Colacioppo P, Robusto F, DEttorre A, et al.
BMJ Open Diabetes Res Care
. 2022 Mar;
10(2).
PMID: 35351688
Background: Coexistent heart failure (HF) and diabetes mellitus (DM) are associated with marked morbidity and mortality. Optimizing treatment strategies can reduce the number and severity of events. Insulin is frequently...
4.
Nacchiero E, Elia R, De Cosmo A, Robusto F
Microsurgery
. 2022 Feb;
42(4):395-396.
PMID: 35218069
No abstract available.
5.
Nacchiero E, Maruccia M, Robusto F, Elia R, Di Cosmo A, Giudice G
Medicina (Kaunas)
. 2022 Jan;
58(1).
PMID: 35056425
: Current guidelines have limited the performance of complete lymph node dissection (CLND) for patients with clinically detectable lymphatic metastases. Despite the limitations of this surgical procedure, secondary lymphedema (SL)...
6.
Baviera M, Genovese S, Lepore V, Colacioppo P, Robusto F, Tettamanti M, et al.
Diabetes Obes Metab
. 2021 Feb;
23(7):1484-1495.
PMID: 33606897
Aim: To examine the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with other antihyperglycaemic agents (AHAs) in large and unselected populations of...
7.
Staszewsky L, Robusto F, Lepore V, Bisceglia L, Petrarolo V, DEttorre A, et al.
Breast Cancer Res Treat
. 2020 Jun;
183(1):177-188.
PMID: 32588164
Aims: To assess the existence, components and clinical relevance of cardiac causes of death and cardiovascular (CV) hospitalizations in a population-wide database of patients with breast cancer (BC). Methods And...
8.
Maruccia M, Fatigato G, Elia R, Ragusa L, Vestita M, Nacchiero E, et al.
Microsurgery
. 2020 Apr;
40(5):608-617.
PMID: 32246807
Background: Successful vascular anastomosis is essential for the survival of free tissue transfer. The aim of the study is to review the current literature and perform a meta-analysis to assess...
9.
Moreira J, Figueroa M, Anselmi M, Prandi R, Montano C, Bell D, et al.
Glob Heart
. 2019 Nov;
14(4):373-378.
PMID: 31727267
Background: In contrast with the abundance of global epidemiological descriptive data on cardiovascular diseases and their risk factors, information on the outcomes of real populations prospectively followed up in their...
10.
Robusto F, Bisceglia L, Petrarolo V, Avolio F, Graps E, Attolini E, et al.
BMC Health Serv Res
. 2018 May;
18(1):377.
PMID: 29801489
Background: Ageing is continuously increasing the prevalence of patients with chronic conditions, putting pressure on the sustainability of Healthcare Systems. Chronic Care Models (CCM) have been used to address the...